Benefit of GO according to mutation profile and correlation with CD33 expression. (A) The forest plot shows the HR for EFS in the GO arm vs the control arm for each mutation (with N ≥ 15) and mutation subgroup. (B) The correlation between the HRs and CD33 expression on AML blasts. Each circle represents a subgroup of patients with a mutation. The size of each circle is proportional to the number of patients.